Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary hyperparathyroidism].

A Hertig1, G Maruani, M Paillard

  • 1Service de physiologie, Hôpital Broussais, Paris.

Nephrologie
|December 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Absence of Claudin-10 in the Enamel Organ Alters Its Integrity.

Journal of dental research·2025
Same author

A model of hemodialysis after acute kidney injury in rats.

Intensive care medicine experimental·2023
Same author

SATB2-associated syndrome: characterization of skeletal features and of bone fragility in a prospective cohort of 19 patients.

Orphanet journal of rare diseases·2022
Same author

Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes.

Frontiers in pharmacology·2021
Same author

Are script concordance tests suitable for the assessment of undergraduate students? A multicenter comparative study.

La Revue de medecine interne·2020
Same author

Trajectory of extracellular fluid volume over time and subsequent risks of end-stage kidney disease and mortality in chronic kidney disease: a prospective cohort study.

Journal of internal medicine·2020
Same journal

Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.

Nephrologie·2004
Same journal

[Acute renal failure and 2,8-dihydroxyadeninuria].

Nephrologie·2004
Same journal

[Phototherapy and hemodialysis pruritus].

Nephrologie·2004
Same journal

[Pregnancy and hemodialysis].

Nephrologie·2004
Same journal

[Role of dietary fibers in the nutritional management of chronic renal failure].

Nephrologie·2004
Same journal

[Abstracts of the VI Meeting of the Society of Nephrology and of the Francophone Society of Dialysis. Marseille, France, 28 September-1 October 2004].

Nephrologie·2004
See all related articles

Primary hyperparathyroidism, a common endocrine disorder, involves elevated parathyroid hormone (PTH) secretion. Diagnosis and treatment strategies are evolving, with surgery for symptomatic cases and potential new therapies on the horizon.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Primary hyperparathyroidism is the third most common endocrine disorder.
  • It is characterized by inappropriately elevated parathyroid hormone (PTH) secretion relative to serum calcium levels.
  • The condition is most frequently caused by parathyroid adenoma or, less commonly, parathyroid hyperplasia.

Purpose of the Study:

  • To review the current understanding of primary hyperparathyroidism.
  • To discuss the evolving clinical presentation and diagnostic approaches.
  • To explore proposed tumorigenic mechanisms and future therapeutic strategies.

Main Methods:

  • Literature review of primary hyperparathyroidism.
  • Analysis of proposed molecular mechanisms in parathyroid tumors.

Related Experiment Videos

  • Discussion of clinical presentation and treatment options.

    • Main Results:

    • The clinical presentation has shifted towards milder, asymptomatic forms, often detected through screening.
    • Key tumorigenic mechanisms include PTH gene rearrangements and MEN1 gene mutations.
    • Hypercalcemia mechanisms are better understood, but PTH secretion regulation is still under investigation.

    Conclusions:

    • Primary hyperparathyroidism diagnosis relies on elevated PTH with hypercalcemia.
    • Understanding tumorigenesis and PTH secretion regulation is crucial.
    • Surgery remains the standard for symptomatic disease, with calcium-receptor agonists as a potential future therapy.